Exemestane (Mechanism of Action)

In this article, we will discuss Exemestane (Mechanism of Action). So, let’s get started.

Breast cancer cell growth may be estrogen-dependent. Aromatase is the principal enzyme that converts
androgens to estrogens both in pre- and postmenopausal women. While the main source of estrogen (primarily
estradiol) is the ovary in premenopausal women, the principal source of circulating estrogens in postmenopausal women is from conversion of adrenal and ovarian androgens (androstenedione and testosterone) to estrogens (estrone and estradiol) by the aromatase enzyme in peripheral tissues. Exemestane is an irreversible, steroidal aromatase inactivator, structurally related to the natural substrate androstenedione. It acts as a false substrate for the aromatase enzyme, and is processed to an intermediate that binds irreversibly to the active site of the enzyme, causing its inactivation, an effect also known as “suicide inhibition.” Exemestane significantly lowers circulating estrogen concentrations in postmenopausal women, but has no
detectable effect on adrenal biosynthesis of corticosteroids or aldosterone. Exemestane has no effect on other enzymes involved in the steroidogenic pathway up to a concentration at least 600 times higher than that inhibiting the aromatase enzyme.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.